ADAM9, ADAM metallopeptidase domain 9, 8754

N. diseases: 109; N. variants: 6
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.030 Biomarker disease BEFREE Moreover, as directly targeted by miR-126 in GC, ADAM9 may be a potential target for GC therapeutic treatment which warrants intensive study. 28260063 2017
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.030 Biomarker disease BEFREE Herein, we investigated the biologic mechanism of ADAM9 in the progression, proliferation, and invasion of gastric cancer. 25344581 2014
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.030 Biomarker disease BEFREE ADAM9, 12 and 15 are implicated in the malignant growth of GC cells, perhaps via the interaction with adhesion molecules, or the proteolytic 'shedding' of signaling molecules and the consequent transactivation of their receptors, such as the epithelial growth factor receptor and its ligands. 15586220 2005